Calendar An icon of a desk calendar. Cancel An icon of a circle with a diagonal line across. Caret An icon of a block arrow pointing to the right. Email An icon of a paper envelope. Facebook An icon of the Facebook "f" mark. Google An icon of the Google "G" mark. Linked In An icon of the Linked In "in" mark. Logout An icon representing logout. Profile An icon that resembles human head and shoulders. Telephone An icon of a traditional telephone receiver. Tick An icon of a tick mark. Is Public An icon of a human eye and eyelashes. Is Not Public An icon of a human eye and eyelashes with a diagonal line through it. Pause Icon A two-lined pause icon for stopping interactions. Quote Mark A opening quote mark. Quote Mark A closing quote mark. Arrow An icon of an arrow. Folder An icon of a paper folder. Breaking An icon of an exclamation mark on a circular background. Camera An icon of a digital camera. Caret An icon of a caret arrow. Clock An icon of a clock face. Close An icon of the an X shape. Close Icon An icon used to represent where to interact to collapse or dismiss a component Comment An icon of a speech bubble. Comments An icon of a speech bubble, denoting user comments. Comments An icon of a speech bubble, denoting user comments. Ellipsis An icon of 3 horizontal dots. Envelope An icon of a paper envelope. Facebook An icon of a facebook f logo. Camera An icon of a digital camera. Home An icon of a house. Instagram An icon of the Instagram logo. LinkedIn An icon of the LinkedIn logo. Magnifying Glass An icon of a magnifying glass. Search Icon A magnifying glass icon that is used to represent the function of searching. Menu An icon of 3 horizontal lines. Hamburger Menu Icon An icon used to represent a collapsed menu. Next An icon of an arrow pointing to the right. Notice An explanation mark centred inside a circle. Previous An icon of an arrow pointing to the left. Rating An icon of a star. Tag An icon of a tag. Twitter An icon of the Twitter logo. Video Camera An icon of a video camera shape. Speech Bubble Icon A icon displaying a speech bubble WhatsApp An icon of the WhatsApp logo. Information An icon of an information logo. Plus A mathematical 'plus' symbol. Duration An icon indicating Time. Success Tick An icon of a green tick. Success Tick Timeout An icon of a greyed out success tick. Loading Spinner An icon of a loading spinner. Facebook Messenger An icon of the facebook messenger app logo. Facebook An icon of a facebook f logo. Facebook Messenger An icon of the Twitter app logo. LinkedIn An icon of the LinkedIn logo. WhatsApp Messenger An icon of the Whatsapp messenger app logo. Email An icon of an mail envelope. Copy link A decentered black square over a white square.

New Tayside MND trial is ‘biggest development in research for 20 years’

Dr Ian Morrison, Principal Investigator for MND Smart.
Dr Ian Morrison, Principal Investigator for MND Smart.

A ground-breaking trial into motor neurone disease (MND) will be launched in Tayside on Wednesday.

The clinical trial will test multiple drugs at the same time to find medicines to slow, stop or reverse the progression of the muscle-wasting illness.

Current drugs which have been tested previously but not fully examined, will be re-tested on MND patients and rapidly progressed if found to be effective.

The MND-SMART trial, described as the “biggest and most important development” in the last two decades ,was launched in Edinburgh in March.

It will be rolled out in Tayside , only the second place in the UK to offer the trial, after being delayed due to coronavirus.

Dr Ian Morrison, consultant neurologist and lead for MND in Tayside, said: “The beauty of the trial’s design is if we find out one of the drugs isn’t working we’ll move on to another one.

“We have a whole raft of potential treatments and we can quickly move through them until we get one that works.

“If we do get one that works we can move it on to a phase three trial which means hopefully getting it into clinical use very quickly.

“This whole approach is a very different way of looking at things so it’s very fast moving and very exciting.

“Personally I think this is the biggest and most important development in MND clinical research of the last 20 years.”

Recruitment for trial participants has begun and it is open to patients across Tayside.

Those who have already registered online interest in the trial will be contacted by the team over the coming months to discuss taking part.

The trial team, made up of NHS Tayside, Dundee University and the Euan MacDonald Centre for MND Research at the University of Edinburgh, will focus on two drugs, with a third placebo group.

They will test memantine,  a drug already used to treat Alzheimer’s disease, which is hoped will improve mobility, as well as trazodone, currently used to treat anxiety and depression.

Animal studies have shown trazodone can stop nerve cells from dying, which may delay the progression of MND.

If successful, it is hoped the trial will improve quality of life for patients and extend the current life expectancy of around 18 to 20 months after diagnosis.

MND-SMART is funded by the Euan MacDonald Centre, substantial private donations, MND Scotland and the My Name’5 Doddie Foundation.

The My Name’5 Doddie Foundation, founded by rugby legend Doddie Weir, has been supporting researchers make sure patients’ needs are at the forefront and has given advice around issues like providing medication in liquid form, as patients often struggle to swallow pills.

Dr Morrison added: “I am delighted that Tayside is now the second centre in the UK to recruit patients into this groundbreaking trial.

“MND is a devastating diagnosis to receive and our current treatments have only limited benefit. The MND-SMART trial now offers a real opportunity to assess alternative drugs which may greatly benefit people living with this condition.”

For more information about the trial, please visit www.MND-SMART.org